INTRODUCTION
SITE SEARCH
BPSi Clinical Mental Model
ASSESSMENT
PAIN EKG
>
PAIN EKG - P
>
Predisposition
Precipitation
Pattern
Provocation
Prior Treatments
Palliative
Patient Beliefs
PAIN EKG - Q
>
Quality of Pain
Quality of Life
PAIN EKG - R
>
Region of Pain
Reflexes Affected
Red Flags
Risk Assessment
PAIN EKG - S
>
Severity of Pain
Sensory Abnormalities
Strength Abnormalities
Sanity Issues
PAIN EKG - T
>
Timing of Pain
Testing for Cause
Tolerance for Pain
INTERPRETATION
>
Nociceptive/Peripheral
Neuropathic
Centralized
Complexity
COMMON CONDITIONS
Back Pain Pointers
>
Back Pain Differential
Facet Joint Disease
Radiculopathy
Treatment for Low Back Pain
Do Not Do for Acute LBP
Fibromyalgia Syndrome
>
FMS Signs & Symptoms
FMS Diagnosis
FMS Drug Treatment
FMS Non-Drug Treatment
TREATMENT IN GENERAL
VA-DoD OPIOID 2022 CPG
Module A
Module B
Module C
DRUG TREATMENT
WHO Pain Ladder
Non-Opioids
>
Antidepressants
Anticonvulsants
Miscellaneous
Opioids - General Info
>
General Pointers
Opioid Tx Protocol
Managing Side Effects
Opioid Conversion
Drug Rotation
Common Opioids
Opioid Complications
Tapering Opioids
NALOXONE RESCUE
MONITORING TREATMENT
5 A's
Urine Drug Testing
>
UDT General Pointers
Specific UDT Examples - A
Specific UDT Examples - B
Validating Urine Samples
Monitoring Agreement Issues
State PDMP Links
>
Ohio (pmpaware) Link
Pennsylvania (pmpaware) Link
West Virginia PDMP
TIME TO REFER
LEXICON
Addiction
Substance Use Disorder
Pseudoaddiction
Physical Dependence
Tolerance
Hyperalgesia
Drug Diversion
PAIN & THE MIND
PROVIDER RESOURCES
ADDICTION RESOURCES
PATIENT RESOURCES
USEFUL WEB LINKS
FEEDBACK
DRUG TREATMENT
- Common
Opioids
Methadone
Long acting, unique lack of euphoria, inexpensive
Mu
receptor agonist, NMDA receptor antagonist
effective for neuropathic pain
less opioid-induced tolerance and hyperalgesia
high inter-individual variability
Biphasic renal elimination
a-elimination (6-8 hours), analgesic duration
ß-elimination (30-60 hours), prevents withdrawal symptoms
Switching from another opioid
Stop current opioid
Start methadone, dividing calculated starting dose into Q8H doses
5% of total daily dose may be given Q6H PRN breakthrough pain
Adjust dose only every 5 to 14 days
Opioid-naïve patient
:
2.5 to 10 mg Q8H
Key patient education point
:
same pill size as oxycodone, yet 5 mg methadone 3-4 times as potent as 5 mg oxycodone
QT prolongation and torsade de pointes
higher doses (200 mg), known risk factors for arrhythmia, hypokalemia and other medications that prolong QT
QTc of 450-500
range should raise caution flag to lower dose or look at drug interactions;
>500 could be life threatening
BACK
DailyMed